11-557934-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000329451.8(LMNTD2):c.505C>T(p.Arg169Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,594,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000329451.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNTD2 | NM_173573.3 | c.505C>T | p.Arg169Cys | missense_variant | 5/14 | ENST00000329451.8 | NP_775844.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNTD2 | ENST00000329451.8 | c.505C>T | p.Arg169Cys | missense_variant | 5/14 | 1 | NM_173573.3 | ENSP00000331167 | P1 | |
LMNTD2-AS1 | ENST00000527620.5 | n.340G>A | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
LMNTD2 | ENST00000441853.5 | c.526C>T | p.Arg176Cys | missense_variant | 6/9 | 3 | ENSP00000393529 | |||
LMNTD2 | ENST00000486629.1 | c.535C>T | p.Arg179Cys | missense_variant | 5/7 | 5 | ENSP00000435529 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000262 AC: 6AN: 229394Hom.: 0 AF XY: 0.0000321 AC XY: 4AN XY: 124714
GnomAD4 exome AF: 0.00000832 AC: 12AN: 1441962Hom.: 0 Cov.: 36 AF XY: 0.0000112 AC XY: 8AN XY: 715286
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2023 | The c.505C>T (p.R169C) alteration is located in exon 5 (coding exon 5) of the LMNTD2 gene. This alteration results from a C to T substitution at nucleotide position 505, causing the arginine (R) at amino acid position 169 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at